NEXI (NexImmune, Inc.) Market Value to Book Value Ratio

Have the research-intensive approaches of NexImmune, Inc. (NEXI) succeeded in retaining valuable specialists? The answer is provided by the market-to-book value multiplier history data from GURU.Markets, where the value 0.59 reflects this status. Simultaneously, the company is implementing eco-filtration and green energy in its laboratories; however, NexImmune, Inc. (NEXI) is currently reducing headcount and closing clinical programs, maintaining only a minimal core staff.

NexImmune Corporation (NEXI): Capitalization to Book Value Ratio from 07/04/2022 to 08/04/2024

Financial and market metric breakdowns for NexImmune Inc (NEXI)

- price and consensus price forecast:

Stock Price NexImmune, Inc.|NEXI - Analyst Median Target

- market capitalization data:

Market Value NexImmune Corp|NEXI - Total Enterprise Value

- book capitalization data:

Net Assets per Single Share NexImmune|NEXI - Accounting Capitalization|Market Capitalization to Book Value Ratio neximmune.com|NEXI - Cumulative Company Assets

- debt and liquidity data:

Debt to Equity NexImmune, Inc.|NEXI - Long-Term Liabilities to Capital|Short-Term Debt to Equity NexImmune Corp|NEXI - Company Debts|Debt to Book Capitalization Ratio NexImmune Corp

Fundamental valuation:NexImmune, Inc.

NexImmune, Inc. (NEXI) develops advanced T-cell cancer immunotherapy methods. This ratio compares the current market value of the business to its net assets. By analyzing the price-to-book ratio trend, an investor determines the premium for future growth. High values here reflect the market's confidence in the monetization of the patent portfolio. This confirms the strategic value of the company's intellectual capital.

Competitor analysis